Pingshan Center was shortlisted for 2022 Shenzhen High tech Zone Development Special Plan Innovation Platform Construction Project List (Proof of concept Center, Achievement Industrialization Base)
Establishment of China Resources 39 Shenzhen Bay Laboratory Joint Research Center
Multiple people from Pingshan Center have been selected for the Global Top 2% Lifetime Influence List and 2022 Annual List of Top Scientists
Shenzhen Bay Laboratory Digital Medical Innovation Research Institute
Joining hands with Baoteng Biotechnology, integrating the advantages of both sides, focusing on the construction of major digital medical facilities, research and transformation of cutting-edge diagnostic and innovative treatment technologies, creating a Shanghai Shenzhen bond, and supporting collaborative innovation in the Guangdong Hong Kong Macao industry agreement
The decoration of the nucleic acid drug research institute has been completed
Li Zigang, Executive Director of Pingshan Center, was approved for the 2022 National Biopharmaceutical Technology Innovation Center nucleic acid drug "unveiling and leading" technology innovation project
Employee Stock Ownership Platform Registration
Encourage innovation and entrepreneurship, promote the transformation of scientific and technological achievements, and reward employees who have made important contributions to Pingshan Center
Industrial Transformation Joint Engineering Technology Center
Collaborate with Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. to jointly build an industrial transformation joint engineering technology center. Deeply explore the mechanisms of anti-inflammatory diseases and demonstrate the development and application of peptide drugs.
Collaborate with Shimadzu Enterprise Management (China) Co., Ltd. to jointly build a cooperative laboratory
Joint Medical Experimental Animal Center
Collaborate with Shenzhen Rongwan Biotechnology Co., Ltd. to jointly build the Joint Medical Experimental Animal Center.
Joint Innovation Center
Jointly build a joint innovation center for the transformation of peptide innovative drug industry, accelerate the transformation of the industry, and promote the innovative development of the peptide industry.
Collaborate with Shenzhen Jingshen Pushi Technology Co., Ltd. to jointly build a collaborative innovation and research joint laboratory for traditional Chinese medicine digital medicine
AI enabling polypeptide and small molecule Drug development, and intelligent Drug development database construction
Nucleic Acid Drug Research Institute
The laboratory design and decoration project has completed bidding and started construction
Pingshan Center Phase II Planning and Construction
The production, education and research base of Yuping Mountain High tech Zone will expand to 5000 square meters to support the layout of nucleic acid research institutes and public service platforms.
Neuromedical Instrument Research Institute
Develop products related to physical intervention in the field of brain diseases (including mental and neurological disorders).
Rongwan Biotechnology Co., Ltd
Facing regional needs, establish a joint venture company to cooperate in the operation and maintenance of animal rooms, and accelerate preclinical research.
Thermofly co built platform
Deeply cooperate in high-end mass spectrometry equipment and analytical technology services to promote Drug development, transformation and incubation.
Wu Yundong, Academician of Pingshan Center, and Dr. Li Zigang were selected as the top 2% scientists in the world
Nucleic Acid Drug Research Institute
Hold a seminar, actively implement the deployment of the Science and Technology Innovation Commission, and cooperate with Shenzhen Bay Laboratory to accelerate the implementation of nucleic acid projects.
Establishment of asset management platform
Connect with social resources, pave the way for asset management, promote internal and external scientific research projects, and promote the transformation of achievements.
Interpret and explore hot topics and technologies in the field of proteins and peptides, establish communication platforms, and promote research transformation.
Pingshan Angel Hui
Develop a joint construction plan, provide full cycle and full coverage services, and create an angel innovation ecosystem.
Clinical Medicine Collaboration
Establish a cooperation framework and jointly participate in the construction of a new mechanism medical science academy clinical medical center.
PTMC First Council
Determine the core team, adopt relevant drafts, and formulate the development policy of the center.
Sign strategic cooperation framework agreement with Shenzhen Technology University, joint training of talents and discipline layout.
Co built laboratory
Jointly apply for the "Key Laboratory of Peptide Drug Research Enterprises in Guangdong Province" to promote the integration of industry, academia, and research.
Collaborating with CR Sanjiu to develop a Class 1 targeted new drug "QBH-196" for the treatment of gastric cancer.
Organize the convening of the "International Innovative Drug Technology Development Forum" to facilitate information exchange.
COVID-19 Emergency Tackling
50 reports on the special topic "Research Progress", with over 10 joint research projects approved.
Landing at the Industry, University and Research Base of Pingshan High tech Zone in Shenzhen.
Registered legal person
Shenzhen Bay Laboratory Pingshan Biopharmaceutical R&D and Transformation Center has completed registration.
The People's Government of Pingshan District in Shenzhen signed a strategic cooperation agreement with Shenzhen Bay Laboratory.